Designed and built to cGMP standards.
Innovation meets excellence in both of our state-of-the-art outsourcing facilities. When we opened our Denver, CO facility, it quickly became clear that STAQ Pharma was bridging a critical gap for pharmaceutical supply chain resilience and developing trust in the compounded outsourcing industry. Realizing the urgent need for sterile outsourced medications and drug shortage solutions, we began construction of our second facility in Columbus, OH. Both STAQ Pharma facilities were built from the ground up as 503B Outsourcing Facilities, meeting all cGMP regulations from day one.
STAQ Pharma’s advanced semi-automation systems and rigorous quality control measures ensure that every product adheres to the safety and efficacy standards for 503B facilities, reflecting our commitment to quality.
Denver Facility
The Denver, CO, facility is FDA and DEA-registered and inspected and features over 27,000 square feet of sterile compounding space, offices, and warehouse space. This original facility opened in 2018 and is the backbone of our company, producing approximately 30,000 units per month.
Columbus Facility
The Columbus, OH, facility, which produced its first commercial batch in 2023, is FDA-registered and inspected and is about five times the size of our Denver facility. Built with a vision for innovation in healthcare, the Columbus location has the capacity to handle hazardous drugs, such as oncology medications.